Atlas Trials

N-of-1 Trial: Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy

Clinical trial NCT02142036 · COMPLETED

Trial details

NCT number
NCT02142036
Sponsor
Oslo University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Cancer
Start date
2014-05-01
Primary completion
2018-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.